[go: up one dir, main page]

CN110760545B - 基于miRNA的虾蟹卵巢发育促进剂 - Google Patents

基于miRNA的虾蟹卵巢发育促进剂 Download PDF

Info

Publication number
CN110760545B
CN110760545B CN201911050844.6A CN201911050844A CN110760545B CN 110760545 B CN110760545 B CN 110760545B CN 201911050844 A CN201911050844 A CN 201911050844A CN 110760545 B CN110760545 B CN 110760545B
Authority
CN
China
Prior art keywords
mirna
vih
mir
crab
shrimp
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201911050844.6A
Other languages
English (en)
Other versions
CN110760545A (zh
Inventor
张子平
王艺磊
方志强
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujian Agriculture and Forestry University
Jimei University
Original Assignee
Fujian Agriculture and Forestry University
Jimei University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujian Agriculture and Forestry University, Jimei University filed Critical Fujian Agriculture and Forestry University
Priority to CN201911050844.6A priority Critical patent/CN110760545B/zh
Publication of CN110760545A publication Critical patent/CN110760545A/zh
Application granted granted Critical
Publication of CN110760545B publication Critical patent/CN110760545B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/87Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/89Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microinjection
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/30Rearing or breeding invertebrates
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00Genetically modified animals
    • A01K2217/05Animals comprising random inserted nucleic acids (transgenic)
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00Animals characterised by species
    • A01K2227/70Invertebrates
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00Animals characterised by purpose
    • A01K2267/02Animal zootechnically ameliorated

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Environmental Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Animal Husbandry (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

本发明涉及一种基于microRNA(以下简称miRNA)的促进虾蟹卵巢发育的方法,其特征在于,在眼柄中注射可特异性结合拟穴青蟹眼柄vih的miRNA,从而抑制vih的表达,促进虾蟹卵巢发育。可特异性结合拟穴青蟹眼柄vih的miRNA序列为GUUAUGGAGUGCGUGUCUGGUGAAG。通过体外实验证实其可以有效降低拟穴青蟹vih mRNA的表达,进一步地,在体实验也证实在眼柄中注射该miRNA可抑制拟穴青蟹眼柄vihmRNA的表达。由于miRNA作用的特异性,使其较剪除眼柄的方法的副作用小;由于miRNA的分子量小于抗体,其在眼柄中扩散能力较强,效率高。

Description

基于miRNA的虾蟹卵巢发育促进剂
技术领域
本发明属于生物技术领域,具体涉及一种基于miRNA的虾蟹卵巢发育促进剂。
背景技术
十足目甲壳动物如虾、蟹的性腺发育是由其眼柄分泌的性腺抑制激素(GIH 或VIH)负调控的。因此,抑制其性腺抑制激素的分泌是促进虾、蟹性腺发育的有效手段。最早是通过剪除虾、蟹眼柄的方法来促进虾、蟹的性腺特别是卵巢的发育。但因虾、蟹眼柄分泌的激素除VIH外还有其它激素,因此该法有比较大的负作用如较高的死亡率,较差的卵子质量等。有人尝试了用在眼柄中注射VIH的抗体以抑制VIH的方法来促进虾、蟹的性腺发育。但该法的效率较低,与抗体在眼柄中的扩散能力较低有关,且价格较高。
发明内容
本发明的目的在于提供一个特异性较强,作用效率较高的基于miRNA的虾蟹卵巢发育促进剂。
为实现上述目的,本发明采用如下技术方案:
一种基于microRNA (以下简称miRNA)的促进虾蟹卵巢发育的方法,其特征在于,在眼柄中注射可特异性结合拟穴青蟹眼柄vih的miRNA,从而抑制vih的表达,促进虾蟹卵巢发育。
1.通过生物信息学分析拟穴青蟹眼柄的miRNA组,我们发现了一个可特异性地结合拟穴青蟹眼vih的miRNA,即miRNA-277(以下简称mir-277,其序列为:GUUAUGGAGUGCGUGUCUGGUGAAG)。
2.通过将人工合成的miR-277 mimics (序列为:GUUAUGGAGUGCGUGUCUGGUGAAG)与miR-277mimics NC(序列为:AGGUUGCUUGACGUUGGGGGAGAUU)以及 miR-277 inhibitor(序列为:CUUCACCAGACACGCACUCCAUAAC) 与 miR-277 inhibitor NC (序列为:AAUCUCCCCCAACGUCAAGCAACCU)经过细胞转染进入 HEK293T 细胞,对荧光素酶活性分析发现,miR-277 mimics 与对照组 miR-277 mimics NC 活性相比显著降低,miR-277inhibitor 与对照组 miR-277 inhibitor NC 活性相比显著升高;结果初步验证 miR-277对 vih 有抑制作用。
3.将化学合成的 miR-277 agomir(序列为:GUUAUGGAGUGCGUGUCUGGUGAAG) 与miR-277 antagomir(AAUCUCCCCCAACGUCAAGCAACCU) 注射入拟穴青蟹眼柄基部,检测眼柄中 vih 与 miR-277的相对表达量,结果表明:注射 miR-277 agomir 后眼柄中的miR-277表达量显著升高,而vih的表达量显著降低;注射 miR-277 antagomir 后眼柄中的miR-277表达量显著降低,vih的表达量却显著升高。进一步验证了 miR-277对 vih 的抑制作用。
本发明的优点在于:本发明所建立的基于miRNA的方法,由于miRNA作用的特异性,使其较剪除眼柄的方法的副作用较小;由于miRNA的分子量小于抗体,其在眼柄中扩散能力较强,效率会比较高。
附图说明
图1为miR-277与拟穴青蟹vih的3’-UTR作用的预测结果图;
图2为miR-277 mimics NC与vih的3’-UTR预测结果图;
图3为miR-277 mimics/ mimics NC与pRR-vih-3’-UTR共转染后双荧光素酶报告基因活性结果(p<0.05);
图4为miR-277 inhibitor/ inhibitor NC与pRR-vih-3’-UTR共转染后双荧光素酶报告基因活性结果(p<0.05);
图5为注射miR-277 agomir和miR-277 antagomir后卵巢中卵黄蛋白原vtg基因的相对表达量(p<0.05);
图6为注射miR-277 agomir和miR-277 antagomir后肝胰腺中vtg基因的相对表达量(p<0.05)。
具体实施方式
实施例1
在进行体外实验时,分别将人工合成的miR-277 mimics(序列为:GUUAUGGAGUGCGUGUCUGGUGAAG) / miR-277 mimics NC(序列为:AGGUUGCUUGACGUUGGGGGAGAUU)以及miR-277 inhibitor(序列为:CUUCACCAGACACGCACUCCAUAAC) / miR-277 inhibitor NC(序列为:AAUCUCCCCCAACGUCAAGCAACCU)代替内参质粒与目的质粒pRR-vih-3’-UTR(Zhou M, Jia X,Wan H, et al. miR‐34 regulates reproduction by inhibiting the expression ofMIH, CHH, EcR, and FAMeT genes in mud crab Scylla paramamosain [J]. Molecularreproduction and development, 2019, 86(2): 122-131.)进行共转染,实验采用的脂质体转染试剂为Lipofectamine 2000;目的质粒和内参质粒的比例为3:1;转染试剂和质粒的比例为2.1:1。经过细胞转染进入 HEK293T 细胞后,收集贴壁的细胞并加入细胞裂解液低速离心,取上清液,进行酶活性的测定,向上清液中先加入Luciferase Assay ReagentⅡ(LARII)试剂,记录萤火虫荧光素酶活性值;然后再加入Stop&Glo试剂,随之记录海肾荧光素酶的活性值(两种试剂均避光),前者与后者活性值的比值即为质粒双荧光素酶报告基因的相对活性。通过比较目的质粒分别与miR-277 mimics / miR-277 mimics NC以及miR-277 inhibitor / miR-277 inhibitor NC的荧光素酶报告基因的相对活性分析发现,miR-277 mimics 与对照组 miR-277 mimics NC 活性相比显著降低(图3),miR-277 inhibitor与对照组 miR-277 inhibitor NC 活性相比显著升高(图4);结果初步验证 miR-277 对vih 有抑制作用。
所述pRR-vih-3’-UTR是以pmir‐RB‐REPORTTM(广州市锐博生物科技)为质粒骨架,利用VIH-F/R从拟穴青蟹基因组中扩增出vih-3’-UTR基因,连接至pmir‐RB‐REPORTTM载体上,获得pRR-vih-3’-UTR目的质粒;
VIH-F:5’-CCGCTCGAG GGCACTGAACCTCATTAAACCTTTC-3’;
VIH-R:5’-GAATGCGGCCGC ATTTATCGTTTGATGACTGT-3’。
实施例2
在进行在体实验时,将化学合成的 miR-277 agomir (序列为:GUUAUGGAGUGCGUGUCUGGUGAAG)与 miR-277 antagomir (AAUCUCCCCCAACGUCAAGCAACCU)注射入拟穴青蟹眼柄基部,检测眼柄中 vih 与 miR-277的相对表达量,根据LightCycler480实时荧光定量PCR仪显示出的每个样品的Cp值,计算待测基因的相对表达量(RQ)值,RQ使用比较阈值循环法(ΔΔCT)(ΔCT=目标基因的CT-内参基因的CT,ΔΔCT=ΔCT-校准物样品)来计算所有这些基因的相对表达水平,并用SPSS20.0统计学软件对数据进行单因素方差统计学分析,采用t检验确定各数据处理间的平均值差异,以p<0.05为差异显著。结果表明:注射 miR-277 agomir 后眼柄中的miR-277表达量显著升高,而vih的表达量显著降低;注射 miR-277 antagomir 后眼柄中的miR-277表达量显著降低,vih的表达量却显著升高。进一步验证了 miR-277对 vih 的抑制作用。
在 miR-277 agomir 与 miR-277 antagomir 注射入拟穴青蟹眼柄基部的基础上,检测卵巢和肝胰腺中卵黄蛋白原 vtg 的相对表达量,结果表明:注射 miR-277 agomir后 vtg在卵巢和肝胰腺中的表达量均显著升高,而注射 miR-277 antagomir 后 vtg 在卵巢和肝胰腺中的表达量均显著降低(图5、图6)。说明miR-277可以作为拟穴青蟹卵巢发育促进剂。
以上所述仅为本发明的较佳实施例,凡依本发明申请专利范围所做的均等变化与修饰,皆应属本发明的涵盖范围。
SEQUENCE LISTING
<110> 福建农林大学,集美大学
<120> 基于miRNA的虾蟹卵巢发育促进剂
<130> 6
<160> 6
<170> PatentIn version 3.3
<210> 1
<211> 25
<212> DNA
<213> 人工序列
<400> 1
guuauggagu gcgugucugg ugaag 25
<210> 2
<211> 25
<212> DNA
<213> 人工序列
<400> 2
agguugcuug acguuggggg agauu 25
<210> 3
<211> 25
<212> DNA
<213> 人工序列
<400> 3
cuucaccaga cacgcacucc auaac 25
<210> 4
<211> 25
<212> DNA
<213> 人工序列
<400> 4
aaucuccccc aacgucaagc aaccu 25
<210> 5
<211> 34
<212> DNA
<213> 人工序列
<400> 5
ccgctcgagg gcactgaacc tcattaaacc tttc 34
<210> 6
<211> 32
<212> DNA
<213> 人工序列
<400> 6
gaatgcggcc gcatttatcg tttgatgact gt 32

Claims (1)

1.一种特异性结合拟穴青蟹眼柄vih的miRNA在制备促进虾蟹卵巢发育制剂中的应用,所述miRNA为miR-277,其序列为GUUAUGGAGUGCGUGUCUGGUGAAG;
所述制剂为用于拟穴青蟹眼柄注射用制剂。
CN201911050844.6A 2019-10-31 2019-10-31 基于miRNA的虾蟹卵巢发育促进剂 Active CN110760545B (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201911050844.6A CN110760545B (zh) 2019-10-31 2019-10-31 基于miRNA的虾蟹卵巢发育促进剂

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201911050844.6A CN110760545B (zh) 2019-10-31 2019-10-31 基于miRNA的虾蟹卵巢发育促进剂

Publications (2)

Publication Number Publication Date
CN110760545A CN110760545A (zh) 2020-02-07
CN110760545B true CN110760545B (zh) 2021-05-04

Family

ID=69335093

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201911050844.6A Active CN110760545B (zh) 2019-10-31 2019-10-31 基于miRNA的虾蟹卵巢发育促进剂

Country Status (1)

Country Link
CN (1) CN110760545B (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114107301B (zh) * 2021-12-03 2023-06-27 中国水产科学研究院黄海水产研究所 miR-9在用于制备三疣梭子蟹卵巢发育促进剂中的应用
CN114085839A (zh) * 2021-12-03 2022-02-25 中国水产科学研究院黄海水产研究所 一种与三疣梭子蟹卵巢发育相关的miRNA类似物及其应用
CN114660301B (zh) * 2022-02-25 2025-02-07 中国海洋大学 一种激素诱导日本鳗鲡卵巢发育效果的评价方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018084077A1 (ja) * 2016-11-01 2018-05-11 国立研究開発法人国際農林水産業研究センター 有用エビ類の卵成熟抑制を解除する方法

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018084077A1 (ja) * 2016-11-01 2018-05-11 国立研究開発法人国際農林水産業研究センター 有用エビ類の卵成熟抑制を解除する方法
CN109715806A (zh) * 2016-11-01 2019-05-03 国立研究开发法人国际农林水产业研究中心 解除有用虾类的卵成熟抑制的方法

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
拟穴青蟹 miR-34/miR277/miR279 的表达特征及其对眼柄重要基因的调控;梁萌萌;《cnki中国优秀硕士论文数据库》;20170503;第4,5,24,32页,第38页第2段,第40页图4.1,第1.6.1,3.1.1,3.3.1节 *

Also Published As

Publication number Publication date
CN110760545A (zh) 2020-02-07

Similar Documents

Publication Publication Date Title
CN110760545B (zh) 基于miRNA的虾蟹卵巢发育促进剂
Kushawah et al. CRISPR-Cas13d induces efficient mRNA knockdown in animal embryos
Sassi et al. Cardiac myocyte miR-29 promotes pathological remodeling of the heart by activating Wnt signaling
Su et al. An in vivo method to identify microRNA targets not predicted by computation algorithms: p21 targeting by miR-92a in cancer
Nakagawa et al. Paraspeckles are subpopulation-specific nuclear bodies that are not essential in mice
Zhang et al. RISC-interacting clearing 3’-5’exoribonucleases (RICEs) degrade uridylated cleavage fragments to maintain functional RISC in Arabidopsis thaliana
Schoppee Bortz et al. Chromatin immunoprecipitation (ChIP): revisiting the efficacy of sample preparation, sonication, quantification of sheared DNA, and analysis via PCR
EP3360556B1 (en) Sugar chain-related gene and use thereof
Li et al. An overview on identification and regulatory mechanisms of long non-coding RNAs in fungi
Zhou et al. The long noncoding RNA THBS1-AS1 promotes cardiac fibroblast activation in cardiac fibrosis by regulating TGFBR1
Brown et al. The Beta-adrenergic agonist, Ractopamine, increases skeletal muscle expression of Asparagine Synthetase as part of an integrated stress response gene program
Broadwell et al. Myosin 7b is a regulatory long noncoding RNA (lncMYH7b) in the human heart
Feng et al. Endothelial derived miRNA-9 mediated cardiac fibrosis in diabetes and its regulation by ZFAS1
Carlile et al. Processing of naturally occurring sense/antisense transcripts of the vertebrate Slc34a gene into short RNAs
Zacchini et al. Human dyskerin binds to cytoplasmic H/ACA-box-containing transcripts affecting nuclear hormone receptor dependence
Perna et al. TF-ChIP method for tissue-specific gene targets
Niu et al. The long noncoding RNA lncMPD2 inhibits myogenesis by targeting the miR-34a-5p/THBS1 axis
CN103695427B (zh) 用于敲低vps11的小分子干扰rna、重组载体及其应用
Soler et al. A systems approach to analyze transcription factors in mammalian cells
Ogami et al. Protocol for analyzing intact mRNA poly (A) tail length using nanopore direct RNA sequencing
CN116356431A (zh) 基于牛全基因组CRISPR-Cas9敲除文库、敲除细胞库及筛选目标基因的方法
CN103695426B (zh) 用于敲低Syntaxin7的小分子干扰RNA、重组载体及其应用
CN107419026A (zh) 猪脂肪沉积相关UCP2 mRNA m6A甲基化单位点的鉴定方法和功能应用
US20230193341A1 (en) Expression systems, recombinant cells and uses thereof
JP2022530940A (ja) Riscに関連した機能性小分子rnaを精製するための方法及びキット

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant